TMO · Thermo Fisher Scientific

S&P 500 #64 · NYSE

Risiko 4/10 · Quality compounder — off 52w high · $576.41 ▲ 3.02%

Kennzahlen

• Price $576.41
• Market cap $214.2B
• P/E (ttm) 31.02
• Div yield 0.34%
• 52-wk range $435.27 – $643.99
• Index rank #64 / —

Wichtigste Risiken

• China revenue headwinds (tariffs/decoupling) (~20% of revenue at risk) — HIGH
• Biotech/pharma R&D budget cuts (Life science tools demand) — HIGH
• COVID tailwind normalization still ongoing (Organic growth rate perception) — MED
• Integration risk from large M&A history (Capital efficiency) — LOW

Fazit

Thermo Fisher is the premier life-science tools and services platform, down ~20% from its 52-week high as biopharma capex caution and China headwinds weigh, creating a potential value window in a high-quality compounder.

Interaktive Analyse öffnen → Teilen

Recherche, keine Anlageberatung.